Andexxa
Payments companies reported to CMS as associated with Andexxa. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Andexxa, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Andexxa
These are the largest totals companies reported as associated with Andexxa. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Fariborz Rezai | Livingston, NJ | Critical Care Medicine (Internal Medicine) | $217,166.13 |
| Nirav Patel | Los Alamitos, CA | Neurology (Psychiatry & Neurology) | $207,234.00 |
| Anne Alexandrov | Memphis, TN | Acute Care (Nurse Practitioner) | $90,261.25 |
| James Neuenschwander | Mount Vernon, OH | Emergency Medicine | $88,648.70 |
| Billy Morgan | Waco, TX | Trauma Surgery | $81,916.74 |
| Niels Martin | Philadelphia, PA | Trauma Surgery | $80,635.30 |
| Latha Ganti | Gainesville, FL | Emergency Medicine | $69,314.48 |
| Aaron Strumwasser | Lynwood, CA | Surgical Critical Care | $57,931.51 |
| Jason Wilson | Tampa, FL | Emergency Medicine | $51,813.74 |
| Rajiv Malhotra | Richmond, VA | Critical Care Medicine (Internal Medicine) | $51,019.41 |
Prescribed Andexxa?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.